Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Department of Applied Biology and Chemical Technology | en_US |
| dc.contributor.advisor | Leung, Y. C.Thomas (ABCT) | en_US |
| dc.creator | Wei, Xinlei | en_US |
| dc.identifier.uri | https://theses.lib.polyu.edu.hk/handle/200/8041 | - |
| dc.language | English | en_US |
| dc.publisher | Hong Kong Polytechnic University | en_US |
| dc.rights | All rights reserved | en_US |
| dc.title | Arginine decarboxylase (ADC) : preparation, expression, purification and test of anti-cancer properties | en_US |
| dcterms.abstract | Arginine metabolic enzymes are being investigated worldwide as agents for cancer treatment, because many tumor cells are auxotrophic for arginine. Biosynthetic arginine decarboxylase (ADC), an enzyme that catalyzes the conversion of arginine to agmatine and carbon dioxide, possesses anti-tumor activity yet has received much less attention than the other two argininedepleting enzymes – arginine deiminase (ADI) and arginase. In order to gain a better understanding of ADC, the expression, purification and anticancer properties of this enzyme originates from Escherichia coli were explored in this project. | en_US |
| dcterms.abstract | ADC tagged with 6 histidine residues was expressed in E. coli grown in shake flask and had undergone a single-step affinity chromatographic purification. Typically, around 110 mg of ADC can be purified from E. coli grown in 1 L culture medium. Purified ADC is of around 28.9 ± 2.7 units/mg at 37°C and pH 8.0, and remains relatively stable for at least 6 months when stored at 4°C in darkness. | en_US |
| dcterms.abstract | When tested in vitro, ADC inhibits the proliferation of ten cell lines of different human cancer types, with IC50 values ranging from 3.8 to 38.1 μg/ml, yet is relatively safer in a non-tumorous cell line. Further in vitro studies focusing on HCT116 and LoVo colorectal cancer cells indicates that ADC induces S and/or G2/M phase arrest as well as intensive apoptosis in these cells. The ADC-induced apoptosis follows the mitochondrial apoptotic pathway and is caspase-3-dependent in HCT116 cells but not in LoVo cells. Autophagy, surprisingly, is not observed in either cell lines. In fact, the antiproliferation effect of ADC in HCT116 cells is antagonized by the autophagy inhibitor hydroxychloroquine (HCQ). Related to these effects, multiple pathways in HCT116 cells may have been altered by the treatment of ADC, including the inhibition of extracellular regulated protein kinase (ERK) activity and the activation of Akt through phosphorylation. Further drug combination studies suggest that ADC is synergistic with doxorubicin and LY204002 at high doses, while antagonistic to verapamil at all doses. | en_US |
| dcterms.abstract | To proceed to in vivo studies, a major challenge for a protein drug is the extension of its blood circulation half-life. To tackle this problem, ADC fused with an albumin binding domain (ABD) has been tested in this project. Having the specific activity of ADC almost fully retained, ADCABD is even more potent than ADC in vitro but fails to prolong the arginine-depletion effect in vivo. The Bacillus caldovelox arginase (BCA)- ABD fusion protein (BHA), however, decreases serum arginine to an undetectable level for a much longer period (24 h) than that when using native BCA (2 h), thus proves the feasibility of the ABD fusion strategy. | en_US |
| dcterms.abstract | With all results obtained, we suggest that ADC has the potential to be a competent drug material due to its simple production process, satisfactory stability, as well as the broad anti-cancer spectrum with high efficacy. Therefore, ADC is worthy to be more deeply investigated in the future. | en_US |
| dcterms.extent | xxx, 322 pages : color illustrations | en_US |
| dcterms.isPartOf | PolyU Electronic Theses | en_US |
| dcterms.issued | 2015 | en_US |
| dcterms.educationalLevel | All Doctorate | en_US |
| dcterms.educationalLevel | Ph.D. | en_US |
| dcterms.LCSH | Arginine | en_US |
| dcterms.LCSH | Arginine -- Therapeutic use | en_US |
| dcterms.LCSH | Decarboxylation | en_US |
| dcterms.LCSH | Hong Kong Polytechnic University -- Dissertations | en_US |
| dcterms.accessRights | open access | en_US |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| b28157680.pdf | For All Users | 5.14 MB | Adobe PDF | View/Open |
Copyright Undertaking
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item:
https://theses.lib.polyu.edu.hk/handle/200/8041